Willingness to use tamoxifen to prevent breast cancer among diverse women

Breast Cancer Research and Treatment

Volumn 133, Issue 1, 2012, Pages 357-366

  Kaplan, Celia Patricia ^a,b,c   Kim, Sue E ^d   Wong, Sabrina T ^e   Sawaya, George F ^a,b   Walsh, Judith M E ^a,b   Pérez Stable, Eliseo J ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Health and Barriers to Employment   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Breast cancer prevention; Chemoprevention therapy; Minority populations; Numeracy; Tamoxifen

Indexed keywords

TAMOXIFEN;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; AMBULATORY CARE; ARTICLE; ASIAN; BREAST CANCER; CANCER PREVENTION; CAUCASIAN; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFICACY; DRUG SAFETY; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; FAMILY HISTORY; FEMALE; GENERAL PRACTITIONER; HEALTH INSURANCE; HEALTH STATUS; HEALTH SURVEY; HIGH RISK POPULATION; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MEDICAL HISTORY; PATIENT ATTITUDE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK BENEFIT ANALYSIS;

AFRICAN AMERICANS; AGED; ANTICARCINOGENIC AGENTS; ASIAN AMERICANS; BREAST NEOPLASMS; EDUCATIONAL STATUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HISPANIC AMERICANS; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT ACCEPTANCE OF HEALTH CARE; REGRESSION ANALYSIS; RISK FACTORS; TAMOXIFEN;

EID: 84862786906     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-1960-5     Document Type: Article

References (20)

1. A Jemal R Siegel E Ward T Murray J Xu MJ Thun 2007 Cancer statistics, 2007 CA Cancer J Clin 57 1 43 66 17237035 10.3322/canjclin.57.1.43 (Pubitemid 46148091)
2. RT Chlebowski 2002 Breast cancer risk reduction: strategies for women at increased risk Annu Rev Med 53 519 540 11818488 10.1146/annurev.med.53.082901. 103925 1:CAS:528:DC%2BD38Xitl2mtL4%3D (Pubitemid 34177894)
3. AHRQ (2007) The guide to clinical preventive services. Recommendations of the U.S. preventive services task force. The Agency for Healthcare Research and Quality
4. B Fisher JP Costantino DL Wickerham CK Redmond M Kavanah WM Cronin V Vogel A Robidoux N Dimitrov J Atkins, et al. 1998 Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J Natl Cancer Inst 90 18 1371 1388 9747868 10.1093/jnci/90.18.1371 1:CAS:528:DyaK1cXmtlelurs%3D (Pubitemid 28439961)
5. VG Vogel JP Costantino DL Wickerham WM Cronin RS Cecchini JN Atkins TB Bevers L Fehrenbacher ER Pajon Jr JL Wade 3rd, et al. 2006 Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP study of tamoxifen and raloxifene (STAR) P-2 trial JAMA 295 23 2727 2741 16754727 10.1001/jama.295.23.joc60074 1:CAS:528: DC%2BD28XmtFOltLc%3D
6. L Bastian I Lipkus M Kuchibhatla H Weng S Halabi P Ryan C Skinner B Rimer 2001 Women's interest in chemoprevention for breast cancer Arch Intern Med 161 1639 1644 11434796 10.1001/archinte.161.13.1639 1:STN:280:DC%2BD3MvhsFalsw%3D%3D (Pubitemid 32681145)
7. R Taylor K Taguchi 2005 Tamoxifen for breast cancer chemoprevention: low uptake by high-risk women after evaluation of a breast lump Ann Fam Med 3 3 242 247 15928228 10.1370/afm.284 (Pubitemid 40806718)
8. SL Bober LA Hoke RB Duda MM Regan NM Tung 2004 Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors J Clin Oncol 22 24 4951 4957 15598980 10.1200/JCO.2004.05.192 (Pubitemid 46638620)
9. J Melnikow D Paterniti R Azari C Kuenneth S Birch M Kuppermann J Nuovo J Keyzer S Henderson 2005 Preferences of women evaluating risks of tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction Cancer 103 10 1996 2005 15825209 10.1002/cncr.20981 1:CAS:528: DC%2BD2MXkslyltLk%3D (Pubitemid 40605105)
10. J Tchou N Hou A Rademaker VC Jordan M Morrow 2004 Acceptance of tamoxifen chemoprevention by physicians and women at risk Cancer 100 9 1800 1806 15112259 10.1002/cncr.20205 (Pubitemid 38529556)
11. C Kaplan J Haas EJ Pérez-Stable S Gregorich C Somkin G Des Jarlais K Kerlikowske 2006 Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups Cancer Epidemiol Biomark Prev 15 1 162 166 10.1158/1055-9965.EPI-04-0758
12. S Kim EJ Pérez-Stable S Wong S Gregorich G Sawaya J Walsh C Kaplan 2008 Association between cancer risk perception and screening behavior among diverse women Arch Intern Med 168 7 728 734 18413555 10.1001/archinte.168.7.728 (Pubitemid 351563956)
13. A Fagerlin B Zikmund-Fisher DM Smith N Vijayan H Derry J McClure S Greene A Stark S Alford P Lantz, et al. 2010 Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid Breast Cancer Res Treat 119 613 620 19908143 10.1007/s10549-009-0618-4
14. TD Denberg S Wong A Beattie 2005 Women's misconceptions about cancer screening: implications for informed decision-making Patient Educ Couns 57 3 280 285 15893209 10.1016/j.pec.2004.07.015 (Pubitemid 40694006)
15. LD Harris-Kojetin FJ Fowler Jr JA Brown JA Schnaier SF Sweeny 1999 The use of cognitive testing to develop and evaluate CAHPS 1.0 core survey items. Consumer assessment of health plans study Med Care 37 3 Suppl MS10 MS21 10098555 10.1097/00005650-199903001-00002 1:STN:280:DyaK1M7ps1Wqsw%3D%3D
16. L Schwartz S Woloshin W Black H Welch 1997 The role of numeracy in understanding the benefit of screening mammography Ann Intern Med 127 11 966 972 9412301 1:STN:280:DyaK1c%2FjtF2ltw%3D%3D (Pubitemid 27516607)
17. Wong S, Pérez-Stable EJ, Kim S, Gregorich S, Sawaya G, Walsh J, Washington A, Kaplan C (2012) Using visual displays to communicate risk of cancer to diverse women. Patient Educ Couns. doi: 10.1016/j.pec.2011.11.014
18. ER Port LL Montgomery AS Heerdt PI Borgen 2001 Patient reluctance toward tamoxifen use for breast cancer primary prevention Ann Surg Oncol 8 7 580 585 11508619 10.1007/s10434-001-0580-9 1:STN:280:DC%2BD3MvmtlKgtg%3D%3D (Pubitemid 32735038)
19. J Haas C Kaplan G Des Jarlais V Gildengoin EJ Pérez-Stable K Kerlikowske 2005 Perceived risk of breast cancer among women at average and increased risk J Womens Health (Larchmt) 14 9 845 851 10.1089/jwh.2005.14.845 (Pubitemid 43019896)
20. ST Wong W Chen JL Bottorff TG Hislop 2008 Treatment decision making among Chinese women with DCIS J Psychosoc Oncol 26 4 53 73 19042272 10.1080/07347330802359594